Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J
Estimating the economically justifiable price of nirsevimab vs. Standard of Practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: A cost-utility modeling study
BMJ Public Health. 2025;3(2):e002441. doi: 10.1136/bmjph-2024-002441
Harper DM, Navarro-Alonso JA, Bosh FX, Paavonen J, Stanley M, Sasieni P, Yébenes M, Martínez-Martínez N, Rodríguez A, García A, Martín-Gómez L, Vallejo-Aparicio L, Carrión H, Ruiz García Y
Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.
Hum Vaccin Immunother. 2025 (1):2497608. doi: 10.1080/21645515.2025.2497608
Gómez-Peralta F, Robles-Plaza M, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Ampudia-Blasco FJ
Clinical and Economic Value of Flash Glucose Monitoring Systems in the Management of People with Type 2 Diabetes Mellitus on Basal Insulin and Poor Glycemic Control
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Ampudia-Blasco FJ, Oyagüez I, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Gómez-Peralta F
Cost Analysis of FreeStyle Libre® Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c > 8%): A Societal Perspective in Spain
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Paladio-Duran N, Salinas-Ortega L, de la Cuadra-Grande A, Oyagüez I
Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective
62nd European Renal Association (ERA) Congress. Viena. 4-7 jun 2025
Zaragoza R, Estella A, Nuvials X, Robles M, Casado A